Post-earnings recap
Reported
Tue, Mar 29, 2022
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
88%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
CorMedix Inc. reported a loss per share of $0.20, which was better than expected, but did not provide revenue figures. The stock reacted negatively, declining by 2.12%. The lack of revenue data and guidance may have contributed to investor uncertainty.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.20 | N/A | +9.09% |
| Revenue | — | N/A | — |
No transcript is on record for the earnings call, and the analysis is based solely on numerical results.